[ad_1]
“Any technology stock with an AI story is rising too far and too fast,” veteran trader Jeffrey Bierman says.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...